Biologic Therapy in Pregnant Women with Plaque Psoriasis: A Narrative Review of Maternal and Fetal Safety Considerations

Shilpa Nagendra, Emmanouil Karampinis

Open source

DOI
10.3390/ph19091467
Published
2026-09-16
Container
Pharmaceuticals
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091467,
  title = {Biologic Therapy in Pregnant Women with Plaque Psoriasis: A Narrative Review of Maternal and Fetal Safety Considerations},
  author = {Shilpa Nagendra and Emmanouil Karampinis},
  year = {2026},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph19091467},
  url = {https://doi.org/10.3390/ph19091467}
}

RIS

TY  - JOUR
TI  - Biologic Therapy in Pregnant Women with Plaque Psoriasis: A Narrative Review of Maternal and Fetal Safety Considerations
AU  - Shilpa Nagendra
AU  - Emmanouil Karampinis
PY  - 2026
JO  - Pharmaceuticals
DO  - 10.3390/ph19091467
UR  - https://doi.org/10.3390/ph19091467
ER  - 

APA

Nagendra, S., & Karampinis, E. (2026). Biologic Therapy in Pregnant Women with Plaque Psoriasis: A Narrative Review of Maternal and Fetal Safety Considerations. Pharmaceuticals. https://doi.org/10.3390/ph19091467

Source records